Related references
Note: Only part of the references are listed.Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
B. Sunde et al.
DISEASES OF THE ESOPHAGUS (2019)
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial
Bo Jan Noordman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
Zebedee Jammbe Musoro et al.
BMJ OPEN (2018)
Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial
B. J. Noordman et al.
ANNALS OF ONCOLOGY (2018)
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee et al.
LANCET ONCOLOGY (2017)
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
J. V. Reynolds et al.
BMC CANCER (2017)
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
F. Klevebro et al.
ANNALS OF ONCOLOGY (2016)
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Jens Hoeppner et al.
BMC CANCER (2016)
Health-related quality of life 10 years after oesophageal cancer surgery
Anna Schandl et al.
EUROPEAN JOURNAL OF CANCER (2016)
No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base
Eisar Al-Sukhni et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer
Gabriella Alexandersson von Dobeln et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Core information set for oesophageal cancer surgery
J. M. Blazeby et al.
BRITISH JOURNAL OF SURGERY (2015)
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
F. Klevebro et al.
EJSO (2015)
Radiation-related heart and vascular disease
Syed Wamique Yusuf et al.
FUTURE ONCOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction - a prospective cohort pilot study within a randomized clinical trial
Mikael Lund et al.
RADIATION ONCOLOGY (2015)
Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery
M. Jacobs et al.
QUALITY OF LIFE RESEARCH (2014)
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
Ulrich Ronellenfitsch et al.
EUROPEAN JOURNAL OF CANCER (2013)
Acute Cardiac Impairment Associated With Concurrent Chemoradiotherapy for Esophageal Cancer: Magnetic Resonance Evaluation
Masamitsu Hatakenaka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Influence of Major Postoperative Complications on Health-Related Quality of Life Among Long-Term Survivors of Esophageal Cancer Surgery
Maryam Derogar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan H. Burmeister et al.
EUROPEAN JOURNAL OF CANCER (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
RADIATION-RELATED HEART DISEASE: CURRENT KNOWLEDGE AND FUTURE PROSPECTS
Sarah C. Darby et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Michael Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-term health-related quality of life following surgery for oesophageal cancer
T. Djarv et al.
BRITISH JOURNAL OF SURGERY (2008)
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach
Pernilla Lagergren et al.
EUROPEAN JOURNAL OF CANCER (2007)
Health-related quality of life among patients cured by surgery for esophageal cancer
Pernilla Lagergren et al.
CANCER (2007)
Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma
JM Blazeby et al.
CANCER (2005)
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
JM Blazeby et al.
EUROPEAN JOURNAL OF CANCER (2003)